1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Cyclooxygenase 2 Inhibitor Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Selective Cox 2 Inhibitor 1.2.3 Non-Selective Cox 2 Inhibitor 1.3 Market by Application 1.3.1 Global Cyclooxygenase 2 Inhibitor Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Specialty Clinic 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Cyclooxygenase 2 Inhibitor Market Perspective (2016-2027) 2.2 Cyclooxygenase 2 Inhibitor Growth Trends by Regions 2.2.1 Cyclooxygenase 2 Inhibitor Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Cyclooxygenase 2 Inhibitor Historic Market Share by Regions (2016-2021) 2.2.3 Cyclooxygenase 2 Inhibitor Forecasted Market Size by Regions (2022-2027) 2.3 Cyclooxygenase 2 Inhibitor Industry Dynamic 2.3.1 Cyclooxygenase 2 Inhibitor Market Trends 2.3.2 Cyclooxygenase 2 Inhibitor Market Drivers 2.3.3 Cyclooxygenase 2 Inhibitor Market Challenges 2.3.4 Cyclooxygenase 2 Inhibitor Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Cyclooxygenase 2 Inhibitor Players by Revenue 3.1.1 Global Top Cyclooxygenase 2 Inhibitor Players by Revenue (2016-2021) 3.1.2 Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Players (2016-2021) 3.2 Global Cyclooxygenase 2 Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Cyclooxygenase 2 Inhibitor Revenue 3.4 Global Cyclooxygenase 2 Inhibitor Market Concentration Ratio 3.4.1 Global Cyclooxygenase 2 Inhibitor Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Cyclooxygenase 2 Inhibitor Revenue in 2020 3.5 Cyclooxygenase 2 Inhibitor Key Players Head office and Area Served 3.6 Key Players Cyclooxygenase 2 Inhibitor Product Solution and Service 3.7 Date of Enter into Cyclooxygenase 2 Inhibitor Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Cyclooxygenase 2 Inhibitor Breakdown Data by Type 4.1 Global Cyclooxygenase 2 Inhibitor Historic Market Size by Type (2016-2021) 4.2 Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Type (2022-2027) 5 Cyclooxygenase 2 Inhibitor Breakdown Data by Application 5.1 Global Cyclooxygenase 2 Inhibitor Historic Market Size by Application (2016-2021) 5.2 Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Cyclooxygenase 2 Inhibitor Market Size (2016-2027) 6.2 North America Cyclooxygenase 2 Inhibitor Market Size by Type 6.2.1 North America Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021) 6.2.2 North America Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027) 6.2.3 North America Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2027) 6.3 North America Cyclooxygenase 2 Inhibitor Market Size by Application 6.3.1 North America Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021) 6.3.2 North America Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027) 6.3.3 North America Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2027) 6.4 North America Cyclooxygenase 2 Inhibitor Market Size by Country 6.4.1 North America Cyclooxygenase 2 Inhibitor Market Size by Country (2016-2021) 6.4.2 North America Cyclooxygenase 2 Inhibitor Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Cyclooxygenase 2 Inhibitor Market Size (2016-2027) 7.2 Europe Cyclooxygenase 2 Inhibitor Market Size by Type 7.2.1 Europe Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021) 7.2.2 Europe Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027) 7.2.3 Europe Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2027) 7.3 Europe Cyclooxygenase 2 Inhibitor Market Size by Application 7.3.1 Europe Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021) 7.3.2 Europe Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027) 7.3.3 Europe Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2027) 7.4 Europe Cyclooxygenase 2 Inhibitor Market Size by Country 7.4.1 Europe Cyclooxygenase 2 Inhibitor Market Size by Country (2016-2021) 7.4.2 Europe Cyclooxygenase 2 Inhibitor Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size (2016-2027) 8.2 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Type 8.2.1 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2027) 8.3 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Application 8.3.1 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2027) 8.4 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Region 8.4.1 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Cyclooxygenase 2 Inhibitor Market Size (2016-2027) 9.2 Latin America Cyclooxygenase 2 Inhibitor Market Size by Type 9.2.1 Latin America Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021) 9.2.2 Latin America Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027) 9.2.3 Latin America Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2027) 9.3 Latin America Cyclooxygenase 2 Inhibitor Market Size by Application 9.3.1 Latin America Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021) 9.3.2 Latin America Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027) 9.3.3 Latin America Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2027) 9.4 Latin America Cyclooxygenase 2 Inhibitor Market Size by Country 9.4.1 Latin America Cyclooxygenase 2 Inhibitor Market Size by Country (2016-2021) 9.4.2 Latin America Cyclooxygenase 2 Inhibitor Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size (2016-2027) 10.2 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Type 10.2.1 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2027) 10.3 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Application 10.3.1 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2027) 10.4 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Country 10.4.1 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Cyclooxygenase 2 Inhibitor Introduction 11.1.4 Pfizer Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) 11.1.5 Pfizer Recent Development 11.2 Bayer 11.2.1 Bayer Company Details 11.2.2 Bayer Business Overview 11.2.3 Bayer Cyclooxygenase 2 Inhibitor Introduction 11.2.4 Bayer Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) 11.2.5 Bayer Recent Development 11.3 Novartis 11.3.1 Novartis Company Details 11.3.2 Novartis Business Overview 11.3.3 Novartis Cyclooxygenase 2 Inhibitor Introduction 11.3.4 Novartis Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) 11.3.5 Novartis Recent Development 11.4 Merck 11.4.1 Merck Company Details 11.4.2 Merck Business Overview 11.4.3 Merck Cyclooxygenase 2 Inhibitor Introduction 11.4.4 Merck Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) 11.4.5 Merck Recent Development 11.5 Sabinsa 11.5.1 Sabinsa Company Details 11.5.2 Sabinsa Business Overview 11.5.3 Sabinsa Cyclooxygenase 2 Inhibitor Introduction 11.5.4 Sabinsa Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) 11.5.5 Sabinsa Recent Development 11.6 Cadila Pharmaceuticals 11.6.1 Cadila Pharmaceuticals Company Details 11.6.2 Cadila Pharmaceuticals Business Overview 11.6.3 Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Introduction 11.6.4 Cadila Pharmaceuticals Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) 11.6.5 Cadila Pharmaceuticals Recent Development 11.7 Mylan 11.7.1 Mylan Company Details 11.7.2 Mylan Business Overview 11.7.3 Mylan Cyclooxygenase 2 Inhibitor Introduction 11.7.4 Mylan Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) 11.7.5 Mylan Recent Development 11.8 Teva Pharmaceutical 11.8.1 Teva Pharmaceutical Company Details 11.8.2 Teva Pharmaceutical Business Overview 11.8.3 Teva Pharmaceutical Cyclooxygenase 2 Inhibitor Introduction 11.8.4 Teva Pharmaceutical Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) 11.8.5 Teva Pharmaceutical Recent Development 11.9 Alembic Pharmaceutical 11.9.1 Alembic Pharmaceutical Company Details 11.9.2 Alembic Pharmaceutical Business Overview 11.9.3 Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Introduction 11.9.4 Alembic Pharmaceutical Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) 11.9.5 Alembic Pharmaceutical Recent Development 11.10 Aurobindo Pharma 11.10.1 Aurobindo Pharma Company Details 11.10.2 Aurobindo Pharma Business Overview 11.10.3 Aurobindo Pharma Cyclooxygenase 2 Inhibitor Introduction 11.10.4 Aurobindo Pharma Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) 11.10.5 Aurobindo Pharma Recent Development 11.11 Cipla 11.11.1 Cipla Company Details 11.11.2 Cipla Business Overview 11.11.3 Cipla Cyclooxygenase 2 Inhibitor Introduction 11.11.4 Cipla Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) 11.11.5 Cipla Recent Development 11.12 Torrent Pharmaceuticals 11.12.1 Torrent Pharmaceuticals Company Details 11.12.2 Torrent Pharmaceuticals Business Overview 11.12.3 Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Introduction 11.12.4 Torrent Pharmaceuticals Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) 11.12.5 Torrent Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Cyclooxygenase 2 Inhibitor Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Selective Cox 2 Inhibitor Table 3. Key Players of Non-Selective Cox 2 Inhibitor Table 4. Global Cyclooxygenase 2 Inhibitor Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Cyclooxygenase 2 Inhibitor Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Cyclooxygenase 2 Inhibitor Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Cyclooxygenase 2 Inhibitor Market Share by Regions (2016-2021) Table 8. Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Cyclooxygenase 2 Inhibitor Market Share by Regions (2022-2027) Table 10. Cyclooxygenase 2 Inhibitor Market Trends Table 11. Cyclooxygenase 2 Inhibitor Market Drivers Table 12. Cyclooxygenase 2 Inhibitor Market Challenges Table 13. Cyclooxygenase 2 Inhibitor Market Restraints Table 14. Global Cyclooxygenase 2 Inhibitor Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Cyclooxygenase 2 Inhibitor Market Share by Players (2016-2021) Table 16. Global Top Cyclooxygenase 2 Inhibitor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cyclooxygenase 2 Inhibitor as of 2020) Table 17. Ranking of Global Top Cyclooxygenase 2 Inhibitor Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Cyclooxygenase 2 Inhibitor Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Cyclooxygenase 2 Inhibitor Product Solution and Service Table 21. Date of Enter into Cyclooxygenase 2 Inhibitor Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021) (US$ Million) Table 24. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Type (2016-2021) Table 25. Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Cyclooxygenase 2 Inhibitor Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Application (2016-2021) Table 29. Global Cyclooxygenase 2 Inhibitor Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021) (US$ Million) Table 32. North America Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021) (US$ Million) Table 34. North America Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Cyclooxygenase 2 Inhibitor Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Cyclooxygenase 2 Inhibitor Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Cyclooxygenase 2 Inhibitor Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Cyclooxygenase 2 Inhibitor Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Cyclooxygenase 2 Inhibitor Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Cyclooxygenase 2 Inhibitor Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size by Country (2022-2027) & (US$ Million) Table 61. Pfizer Company Details Table 62. Pfizer Business Overview Table 63. Pfizer Cyclooxygenase 2 Inhibitor Product Table 64. Pfizer Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million) Table 65. Pfizer Recent Development Table 66. Bayer Company Details Table 67. Bayer Business Overview Table 68. Bayer Cyclooxygenase 2 Inhibitor Product Table 69. Bayer Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million) Table 70. Bayer Recent Development Table 71. Novartis Company Details Table 72. Novartis Business Overview Table 73. Novartis Cyclooxygenase 2 Inhibitor Product Table 74. Novartis Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million) Table 75. Novartis Recent Development Table 76. Merck Company Details Table 77. Merck Business Overview Table 78. Merck Cyclooxygenase 2 Inhibitor Product Table 79. Merck Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million) Table 80. Merck Recent Development Table 81. Sabinsa Company Details Table 82. Sabinsa Business Overview Table 83. Sabinsa Cyclooxygenase 2 Inhibitor Product Table 84. Sabinsa Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million) Table 85. Sabinsa Recent Development Table 86. Cadila Pharmaceuticals Company Details Table 87. Cadila Pharmaceuticals Business Overview Table 88. Cadila Pharmaceuticals Cyclooxygenase 2 Inhibitor Product Table 89. Cadila Pharmaceuticals Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million) Table 90. Cadila Pharmaceuticals Recent Development Table 91. Mylan Company Details Table 92. Mylan Business Overview Table 93. Mylan Cyclooxygenase 2 Inhibitor Product Table 94. Mylan Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million) Table 95. Mylan Recent Development Table 96. Teva Pharmaceutical Company Details Table 97. Teva Pharmaceutical Business Overview Table 98. Teva Pharmaceutical Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million) Table 99. Teva Pharmaceutical Recent Development Table 100. Alembic Pharmaceutical Company Details Table 101. Alembic Pharmaceutical Business Overview Table 102. Alembic Pharmaceutical Cyclooxygenase 2 Inhibitor Product Table 103. Alembic Pharmaceutical Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million) Table 104. Alembic Pharmaceutical Recent Development Table 105. Aurobindo Pharma Company Details Table 106. Aurobindo Pharma Business Overview Table 107. Aurobindo Pharma Cyclooxygenase 2 Inhibitor Product Table 108. Aurobindo Pharma Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million) Table 109. Aurobindo Pharma Recent Development Table 110. Cipla Company Details Table 111. Cipla Business Overview Table 112. Cipla Cyclooxygenase 2 Inhibitor Product Table 113. Cipla Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million) Table 114. Cipla Recent Development Table 115. Torrent Pharmaceuticals Company Details Table 116. Torrent Pharmaceuticals Business Overview Table 117. Torrent Pharmaceuticals Cyclooxygenase 2 Inhibitor Product Table 118. Torrent Pharmaceuticals Revenue in Cyclooxygenase 2 Inhibitor Business (2016-2021) & (US$ Million) Table 119. Torrent Pharmaceuticals Recent Development Table 120. Research Programs/Design for This Report Table 121. Key Data Information from Secondary Sources Table 122. Key Data Information from Primary Sources List of Figures Figure 1. Global Cyclooxygenase 2 Inhibitor Market Share by Type: 2020 VS 2027 Figure 2. Selective Cox 2 Inhibitor Features Figure 3. Non-Selective Cox 2 Inhibitor Features Figure 4. Global Cyclooxygenase 2 Inhibitor Market Share by Application: 2020 VS 2027 Figure 5. Hospital Case Studies Figure 6. Specialty Clinic Case Studies Figure 7. Others Case Studies Figure 8. Cyclooxygenase 2 Inhibitor Report Years Considered Figure 9. Global Cyclooxygenase 2 Inhibitor Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global Cyclooxygenase 2 Inhibitor Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Cyclooxygenase 2 Inhibitor Market Share by Regions: 2020 VS 2027 Figure 12. Global Cyclooxygenase 2 Inhibitor Market Share by Regions (2022-2027) Figure 13. Global Cyclooxygenase 2 Inhibitor Market Share by Players in 2020 Figure 14. Global Top Cyclooxygenase 2 Inhibitor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cyclooxygenase 2 Inhibitor as of 2020 Figure 15. The Top 10 and 5 Players Market Share by Cyclooxygenase 2 Inhibitor Revenue in 2020 Figure 16. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Type (2016-2021) Figure 17. Global Cyclooxygenase 2 Inhibitor Revenue Market Share by Type (2022-2027) Figure 18. North America Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America Cyclooxygenase 2 Inhibitor Market Share by Type (2016-2027) Figure 20. North America Cyclooxygenase 2 Inhibitor Market Share by Application (2016-2027) Figure 21. North America Cyclooxygenase 2 Inhibitor Market Share by Country (2016-2027) Figure 22. United States Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Cyclooxygenase 2 Inhibitor Market Share by Type (2016-2027) Figure 26. Europe Cyclooxygenase 2 Inhibitor Market Share by Application (2016-2027) Figure 27. Europe Cyclooxygenase 2 Inhibitor Market Share by Country (2016-2027) Figure 28. Germany Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Share by Type (2016-2027) Figure 36. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Share by Application (2016-2027) Figure 37. Asia-Pacific Cyclooxygenase 2 Inhibitor Market Share by Region (2016-2027) Figure 38. China Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Cyclooxygenase 2 Inhibitor Market Share by Type (2016-2027) Figure 46. Latin America Cyclooxygenase 2 Inhibitor Market Share by Application (2016-2027) Figure 47. Latin America Cyclooxygenase 2 Inhibitor Market Share by Country (2016-2027) Figure 48. Mexico Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Share by Type (2016-2027) Figure 52. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Share by Application (2016-2027) Figure 53. Middle East & Africa Cyclooxygenase 2 Inhibitor Market Share by Country (2016-2027) Figure 54. Turkey Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE Cyclooxygenase 2 Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Pfizer Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021) Figure 58. Bayer Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021) Figure 59. Novartis Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021) Figure 60. Merck Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021) Figure 61. Sabinsa Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021) Figure 62. Cadila Pharmaceuticals Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021) Figure 63. Mylan Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021) Figure 64. Teva Pharmaceutical Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021) Figure 65. Alembic Pharmaceutical Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021) Figure 66. Aurobindo Pharma Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021) Figure 67. Cipla Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021) Figure 68. Torrent Pharmaceuticals Revenue Growth Rate in Cyclooxygenase 2 Inhibitor Business (2016-2021) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed

Pfizer Bayer Novartis Merck Sabinsa Cadila Pharmaceuticals Mylan Teva Pharmaceutical Alembic Pharmaceutical Aurobindo Pharma Cipla Torrent Pharmaceuticals